Sign In
6 Feb 2017 07:00
06 February 2017
Byotrol plc
("Byotrol" or the "Company")
Director Dealing
Byotrol plc, the specialist anti-microbial technology company, is pleased to announce that on 03 February 2016 John Langlands, Chairman of the Company has purchased 800,000 ordinary shares of 0.25p each ("Ordinary Shares") at a price of 4.195p per Ordinary Share (the "Purchase"). Following the Purchase, Mr. Langlands has an interest in 1,100,000 Ordinary Shares representing 0.41% of the total voting rights of the Company.
Enquiries:
Byotrol plc | 01925 742 000 |
David Traynor - Chief Executive
|
|
finnCap Ltd |
020 7220 0500 |
(Nominated Adviser & Broker) |
|
Geoff Nash/Carl Holmes/James Thompson - Corporate Finance |
|
Mia Gardner - Corporate Broking |
|
|
|
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist in developing, formulating and commercialising cutting-edge antimicrobial technologies.Our patented suite of technologies delivers powerful broad-spectrum efficacy with residual performance optimised against commonly occurring and industry-specific pathogens
Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives.
For more information, please go to www.byotrol.co.uk
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||
a) | Name | John Langlands | ||||||
2. | Reason for the Notification | |||||||
a) | Position/status | Chairman | ||||||
b) | Initial notification/Amendment | Initial | ||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | Byotrol Plc | ||||||
b) | LEI | N/A | ||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the Financial instrument, type of instrument | ordinary shares of 0.25p each | ||||||
Identification code | GB00B0999995 | |||||||
b) | Nature of the transaction | Purchase of Ordinary Shares | ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information: · Aggregated volume · Price | 800,000 ordinary shares of 0.25p each purchased at 4.195p per ordinary share | ||||||
e) | Date of the transaction | 03 February 2017 | ||||||
f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | ||||||
Follow the stocks
